Seastar Medical Holding's Customers Performance

Name: Seastar Medical Holding Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

ICU

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


ICU's Source of Revenues		During the corresponding time, Seastar Medical Holding Corp recorded a revenue increase by 81.95 % year on year, sequentially revenue grew by 24.24 %. While revenue at the Seastar Medical Holding Corp's corporate clients • List of ICU Customers

for the same period Seastar Medical Holding Corp recorded revenue increase by 81.95 % year on year, sequentially revenue grew by 24.24 %.

• List of ICU Customers

Seastar Medical Holding's Business Units


Quelimmune	406.5 %	of total Revenue
Single Reportable Segment	180.49 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Seastar Medical Holding's Comment on Sales, Marketing and Customers

The company provides QUELIMMUNE therapy to patients registered in the SAVE Surveillance Registry, primarily focusing on critically ill pediatric patients with life-threatening acute kidney injury (AKI) and sepsis or septic conditions. Additional customer activations are planned for 2026. The company is also developing SCD therapy for pediatric patients undergoing cardiac surgery to prevent post-operative complications, as well as for adult patients with AKI in the intensive care unit (ICU) receiving continuous renal replacement therapy (CRRT), as investigated in the NEUTRALIZE-AKI pivotal trial. Its target patient populations include adults with immunomodulatory dysregulation, acute or chronic systolic heart failure with worsening renal function due to cardiorenal syndrome or right ventricular dysfunction, and patients awaiting left ventricular assist device implantation. These efforts are supported by multiple FDA Breakthrough Device Designations (BDD).

Seastar Medical Holding’s Comment on Sales, Marketing and Customers

ICU's Stock Performance relative to it's Customers

ICU's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Seastar Medical Holding Corp	12.42	1.44	-11.90	17
SUBTOTAL	0.00	0.00	0.00	-

Sources: Seastar Medical Holding Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Seastar Medical Holding Corp’s corporate clients.
For your research, we’ve provided 9 tables on Seastar Medical Holding Corp corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.